Table 3.
Comparison of the adverse events between the EST and EPLBD groups.
EST | EPLBD | P value | |
---|---|---|---|
(n = 60) | (n = 161) | ||
Pancreatitis | 2 (3.3%) | 8 (5.0%) | 0.73 |
Mild | 2 | 7 | |
Moderate | 0 | 1 | |
Severe | 0 | 0 | |
Hemorrhage | 0 | 0 | — |
Cholangitis | 2 (3.3%) | 3 (1.9%) | 0.62 |
Perforation | 0 | 0 | — |
Overall adverse events | 4 (6.7%) | 11 (6.8%) | 1.00 |